Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Flohr

Showing results (171-180 of 191) with videos related to

Pageof 20
Sort By:
The British Journal of Dermatology|September 18, 2023
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trialCarsten Flohr, Anna Rosala-Hallas, Ashley P Jones, et al.
Pediatric Dermatology|July 6, 2026
Can Systemic Treatment for Childhood Psoriasis Be Stopped in Cases of Remission? Data From the ACMe CohortAhmad Rached, Yuyun Miao, Alain Beauchet, et al.
Clinical and Experimental Dermatology|April 1, 2025
Exposure-response of ciclosporin and methotrexate in children and young people with severe atopic dermatitis: A secondary analysis of the TREatment of severe Atopic dermatitis Trial (TREAT)Mandy Wan, Ashley P Jones, Daniel Maskrey, et al.
The Journal of Investigative Dermatology|September 5, 2025
Implementing Federated Analysis using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries CollaborationNiels Steen Krogh, David Prieto-Merino, Bolaji Coker, et al.
The British Journal of Dermatology|February 29, 2024
Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspectiveRavi Ramessur, Nick Dand, Sinéad M Langan, et al.
Journal of the American Academy of Dermatology|February 11, 2024
Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patientsHeather A Brandling-Bennett, Lisa M Arkin, Yvonne E Chiu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 28, 2022
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registryAnnelie H Musters, Conor Broderick, David Prieto-Merino, et al.
Pediatric Dermatology|June 14, 2023
Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelinesElaine C Siegfried, Lisa M Arkin, Yvonne E Chiu, et al.
Journal of the American Academy of Dermatology|August 15, 2017
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema CouncilEric L Simpson, Marjolein Bruin-Weller, Carsten Flohr, et al.
Clinics in Dermatology|September 14, 2021
Learning from disease registries during a pandemic: Moving toward an international federation of patient registriesDmitri Wall, Raed Alhusayen, Bernd Arents, et al.
Pageof 20

Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
The British Journal of Dermatology|September 18, 2023
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trialCarsten Flohr, Anna Rosala-Hallas, Ashley P Jones, et al.
Pediatric Dermatology|July 6, 2026
Can Systemic Treatment for Childhood Psoriasis Be Stopped in Cases of Remission? Data From the ACMe CohortAhmad Rached, Yuyun Miao, Alain Beauchet, et al.
Clinical and Experimental Dermatology|April 1, 2025
Exposure-response of ciclosporin and methotrexate in children and young people with severe atopic dermatitis: A secondary analysis of the TREatment of severe Atopic dermatitis Trial (TREAT)Mandy Wan, Ashley P Jones, Daniel Maskrey, et al.
The Journal of Investigative Dermatology|September 5, 2025
Implementing Federated Analysis using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries CollaborationNiels Steen Krogh, David Prieto-Merino, Bolaji Coker, et al.
The British Journal of Dermatology|February 29, 2024
Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspectiveRavi Ramessur, Nick Dand, Sinéad M Langan, et al.
Journal of the American Academy of Dermatology|February 11, 2024
Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patientsHeather A Brandling-Bennett, Lisa M Arkin, Yvonne E Chiu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 28, 2022
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registryAnnelie H Musters, Conor Broderick, David Prieto-Merino, et al.
Pediatric Dermatology|June 14, 2023
Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelinesElaine C Siegfried, Lisa M Arkin, Yvonne E Chiu, et al.
Journal of the American Academy of Dermatology|August 15, 2017
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema CouncilEric L Simpson, Marjolein Bruin-Weller, Carsten Flohr, et al.
Clinics in Dermatology|September 14, 2021
Learning from disease registries during a pandemic: Moving toward an international federation of patient registriesDmitri Wall, Raed Alhusayen, Bernd Arents, et al.
Pageof 20